SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer. Photo by Adobe Stock/HealthDay News A "watch-and-wait" strategy might be the best option ...

The incidence of invasive breast cancer after conservative treatment for ductal carcinoma in situ (DCIS) decreased by more than 50% over the past 30 years, data from a Dutch cancer registry showed.

A newly released study is challenging the way doctors commonly treat patients with ductal carcinoma in situ (DCIS), known as stage zero breast cancer. DCIS cancer cells are confined inside a milk duct ...

Women with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring showed similar quality of life (QOL), anxiety levels, and symptom trajectories compared with those receiving surgery ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. DURHAM, N.C. (WNCN) — A Duke Researcher’s ...

Cancer is typically treated with surgery, radiation and sometimes chemotherapy. But a new study suggests this standard protocol might not be necessary for a common form of early-stage breast cancer.

SAN ANTONIO – For patients with “good-risk” ductal carcinoma in situ (DCIS) who underwent breast- conserving surgery and did not receive radiotherapy, tamoxifen significantly decreased the risk of ...

A new LOCAL online community built for you. Click now to see all the available groups. Watchful waiting appears to serve women with DCIS just as well as going ahead with surgery Women in active ...

Patients with low-risk ductal carcinoma in situ (DCIS) who skipped adjuvant radiotherapy after breast-conserving surgery had comparable five-year outcomes to those with high-risk DCIS who received ...